• Theranostic Radiopharmaceuticals : at the Inflection Point, Jean-François Chatal, Françoise Bodere-Kraeber, Caroline Rousseau, Ferid Haddad, British Journal of Cancer Research, 2019, 2 (2), pp.264-269.

  • Very high specific activity erbium 169Er production for potential receptor-targeted radiotherapy, Formento-Cavaier R, Köster U, Crepieux B, Gadelshin VM, Haddad F, Stora T, et al., Nuclear Instruments and Methods in Physics Research Section B: Beam Interactions with Materials and Atoms. janv 2020;463:468‑71.

  • MELISSA : Laser ion source setup at CERN-MEDICIS facility. Blueprint, Gadelshin VM, Barozier V, Cocolios TE, Fedosseev VN, Formento-Cavaier R, Haddad F, et al., Nuclear Instruments and Methods in Physics Research Section B: Beam Interactions with Materials and Atoms. janv 2020;463:460‑3.

  • Promising Scandium Radionuclides for Nuclear Medicine: A Review on the Production and Chemistry up to In Vivo Proofs of Concept, Huclier-Markai S, Alliot C, Kerdjoudj R, Mougin-Degraef M, Chouin N,  Haddad F. Cancer Biother Radiopharm. 2018, 33: 316-329

  • Alphatherapy, the new impetus to targeted radionuclide therapy? Chatal JF, Kraeber-Bodéré F, Chérel M, Haddad F, Eur J Nucl Med Mol Imaging 2018, 45:1362-1363